Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129202 | SCV000183946 | likely benign | Hereditary cancer-predisposing syndrome | 2021-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000129202 | SCV000289067 | benign | Hereditary cancer-predisposing syndrome | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000662532 | SCV000785102 | uncertain significance | Nijmegen breakage syndrome-like disorder | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Cancer Genomics Group, |
RCV001030512 | SCV001193712 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2019-05-01 | criteria provided, single submitter | research | |
Sema4, |
RCV000662532 | SCV002538515 | likely benign | Nijmegen breakage syndrome-like disorder | 2022-01-02 | criteria provided, single submitter | curation | |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153413 | SCV003843633 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing |